MOTS-C: The “Centenarian” Peptide for Metabolic Enhancement and Longevity
Introduction:
What’s the difference between those who live to 100 and beyond, and those who find their lifespan cut short? One difference is a special peptide most people have never heard about – MOTS-C.
MOTS-C is a peptide with the power to extend lifespan while enhancing health, vitality, and quality of life, just like the centenarians in the world’s Blue Zones.
However, a significant problem with publicly available information regarding MOTS-C is that most of it appears to be based on outdated science at best, and completely inaccurate science at worst. Because of this, many people never realize its full potential.
But here’s what you need to know: MOTS-C is a peptide that's already inside you, actively working to regulate metabolism, endurance, and cellular health. The problem is that its levels decline with age. That’s why centenarians have higher levels, and why optimizing yours could help you to live longer.
In this article, you will learn what MOTS-C is, the science that is often overlooked by other experts, and how to determine the optimal dose to unlock its full potential for health and longevity. Lastly, I will share with you a secret peptide that can work orally to increase your mitochondria production of MOTS C. This is perfect for those who don’t want to use injection but still get some of the benefits of higher MOTS C levels.
What Is MOTS-C?
Mots C is a mitochondrial derived peptide encoded by mitochondrial DNA. It is transcribed in response to increased mitochondrial demands, such as during endurance exercise. Through its activation of the AICAR-AMPK pathway¹ and stimulation of mitochondrial biogenesis via PGC-1α², MOTS-C enhances mitochondrial function and improves glucose metabolism and metabolic health through downstream mediators Irisin and PPARa³ ⁴ expression that enhance insulin sensitivity and vascular health.
MOTS-C also facilitates the production of the vital coenzyme NAD+, which further supports metabolic health and cellular energy regulation⁵.
MOTS-C contributes to slowing down aging by promoting mitochondrial health, which is one intervention established to prevent the repression of genes associated with increased heterochromatin formation which occurs with aging⁶.
Cardiovascular Benefits:
Activates PPARa downstream from PGC1a for anti-inflammatory effects, improved lipid profiles, and cardioprotection¹⁰.
Because the benefits of Epitalon and Epithalamin often overlap and some of the largest human studies were conducted with Epithalamin, I will explore both in separate sections to provide a comprehensive perspective.
So, we’re left with two options:
Stick with the generic recommendations repeated online.
Dive into the available science to calculate an equivalent human dose, which is precisely what I did.
Using Rodent Studies to Inform Dosage
To refine my recommendations, I analyzed several rodent studies on MOTS-C, each providing valuable insights into its dosing and effects:
•5mg/kg–15mg/kg improved exercise performance in mice, with the higher dose yielding better results specifically in older age¹⁸.
•5mg/kg enhanced vascular calcification reversal in rats¹⁹.
•0.5mg/kg improved diabetes outcomes in rats when combined with daily exercise for eight weeks²⁰.
To translate these findings into human applications, I utilized the Human Equivalent Dose formula, which accounts for species-specific differences in body surface area and drug metabolism²¹:
HED = (Animal Dose/kg) × (Animal Km / Human Km)
Calculated Human Doses for MOTS-C:
•Exercise Performance (15mg/kg mouse dose) = 1.215mg/kg for humans.
•Exercise Performance (5mg/kg mouse dose) = 0.405mg/kg for humans.
•Vascular Calcification (5mg/kg rat dose) = 0.81mg/kg for humans.
•Diabetes + Exercise (0.5mg/kg rat dose) = 0.081mg/kg for humans.
For a 70kg person, these calculations translate to a range of 5.67mg–85.05mg, depending on the desired outcome.
Conclusion:
The often-recommended 5mg dose may suffice for individuals with good metabolic health or those combining MOTS-C with exercise. However, it falls short for addressing more complex conditions like vascular calcification or for achieving peak athletic performance, especially in older individuals.
These conservative recommendations likely stem from the high cost of MOTS-C, prioritizing affordability over efficacy. But we should aim to present optimal dosages, so that those who can afford to invest in their health can unlock the peptide's full potential.
For those seeking a more affordable way to increase mitochondrial efficiency and endogenous MOTS-C production, or for those who prefer to avoid injections, consider Pinealon, a small tripeptide that may enhance MOTS-C levels through its unique mechanism.
Brenden Henry
February 20th 2025